Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DJ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DJ.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DJ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DJ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DJ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.21ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.21ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.21EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.11.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.11.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.11.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.11.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.11.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.11.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KT.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KT.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KT.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KT.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used